Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: Russian Bear who wrote (1097)	8/19/1998 7:53:00 AM
From: David Cathcart	Read Replies (2) \| Respond to of 1826

RB, << One other item I seem to recall from an earlier update of yours is that Salagen script re-order statistics should become known very shortly.>> Good point. In my conversation with Lori, all the talk about MGI-114 efficacy and the Euro deal made me slightly intoxicated. I forgot to ask about the progress of Salagen! If I remember correctly though, Blitzer said in the earlier conversation that it would be at least September before they would have the Salagen re-order data. Assuming the information does become available next month, it will probably be the next quarterly report or conference call when that information is passed along. I agree with you about the next six months. Interesting times... David